Epitomee Med (EPIT) Stock Statistics & Valuation Metrics

Epitomee Med has a market cap or net worth of ₪119.17M. The enterprise value is 171.77M.

Epitomee Med has 30,185,490 shares outstanding. The number of shares has decreased by -2.65% in one year.

Epitomee Med’s return on equity (ROE) is -0.36 and return on invested capital (ROIC) is -32.48%.

The current PE Ratio of Epitomee Med is ―. Epitomee Med’s PEG ratio is -0.01.

In the last 12 months, Epitomee Med had revenue of 734.68K and earned -29.70M in profits. Earnings per share was -0.99.

In the last 12 months, operating cash flow was -36.37M and capital expenditures -7.18M, giving a free cash flow of -43.55M billion.

Epitomee Med pays an annual dividend of ―, resulting in a dividend yield of ―

Epitomee Med upcoming earnings date is ―, ―.

Epitomee Med as a current ratio of 6.23, with Debt / Equity ratio of 27.43%

In the past 12 months, Epitomee Med has paid 0.00 in taxes.

Epitomee Med EV to EBITDA ratio is -5.38, with an EV/FCF ratio of -5.17.

Epitomee Med has ₪25.55M in cash and marketable securities with ₪17.46M in debt, giving a net cash position of ₪8.10M billion.

Gross margin is -218.78%, with operating margin of -4475.12%, and net profit margin of -4043.19%.

The average price target for Epitomee Med is ―, which is 11.43% higher than the current price. The consensus rating is ―